Using augmented reality for breast cancer surgery planning
Part of Cancer clinical trials.
This trial tests whether augmented reality can help doctors locate tumors that cannot be felt during breast cancer surgery. If you are having surgery for a non-palpable breast lesion and need an MRI, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have a breast cancer lesion that could not be felt during a physical exam, confirmed by a biopsy.
- You will have a breast MRI as part of your care at Centre Jean Perrin.
- You can understand and agree to participate in the study.
- You are covered by social security.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new magnetic tracking method to help surgeons precisely locate breast tumors before surgery. It may help improve the accuracy of breast-conserving surgery.
This trial tests an augmented reality (AR) tool to help surgeons locate breast cancer tumors during breast-conserving surgery. You may join if you have a single, small invasive breast tumor and have not had chemotherapy before surgery.
This study tests whether using augmented reality (a computer overlay) during robot-assisted surgery for prostate cancer can help the surgeon remove the cancer more precisely. It may be an option for people with low or intermediate risk prostate cancer who have good erectile function.
This study tests whether augmented reality—a technology that overlays digital images onto the surgeon's view—can help surgeons safely remove small liver tumors. You would receive standard surgery, but the surgeon would use AR guidance to locate and remove your tumor more precisely.
This trial tests whether adding a 3D augmented-reality model to standard robot-assisted prostate surgery can help doctors remove the cancer while better preserving sexual function. It is for men whose MRI shows the cancer may have slightly spread outside the prostate.
This trial uses a special PET/MRI scan combined with artificial intelligence to see if it can predict whether HER2-positive breast cancer will completely disappear after treatment given before surgery. The goal is to learn who might avoid surgery or get a more tailored approach.
Hear when a new Subclinical Breast Cancer Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.